Extracorporeal membrane oxygenation with nafamostat mesilate as an anticoagulant for massive pulmonary hemorrhage after living-donor lobar lung transplantation.
Kotani
Kazutoshi
K
Departments of Oncology and Thoracic Surgery, Emergency Medicine, Cardiovascular Surgery, and Anesthesiology and Resuscitology, Graduate School of Medicine and Dentistry, Okayama University, Okayama, Japan. surgery2@med.okayama-u.ac.jp
Ichiba
Shingo
S
Andou
Masanori
M
Sano
Yoshifumi
Y
Date
Hiroshi
H
Tedoriya
Takeo
T
Goto
Keiji
K
Shimizu
Nobuyoshi
N
D000208:Acute Disease; D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use*; D001550:Benzamidines; D003131:Combined Modality Therapy; D015199:Extracorporeal Membrane Oxygenation; D005260:Female; D006146:Guanidines / Q000627:therapeutic use*; D006470:Hemorrhage / Q000150:complications / Q000628:therapy*; D006801:Humans; D019520:Living Donors; D008171:Lung Diseases / Q000150:complications / Q000628:therapy*; D016040:Lung Transplantation; D011183:Postoperative Complications / Q000209:etiology / Q000628:therapy; D012131:Respiratory Insufficiency / Q000209:etiology / Q000628:therapy
D000925:Anticoagulants; D001550:Benzamidines; D006146:Guanidines; C032855:nafamostat